| | | Single nucleotide variant (missense variant) | Long QT syndrome | |
| | | Single nucleotide variant (missense variant) | not specified +2 more | |
| | | Single nucleotide variant (missense variant) | not provided +3 more | GBenign/Likely benign; other |
| | | Single nucleotide variant (missense variant) | not provided +2 more | GConflicting classifications of pathogenicity; association |
| | | Single nucleotide variant (3 prime UTR variant) | Rheumatoid arthritis +1 more | |
| | | Single nucleotide variant (intron variant) | Rheumatoid arthritis +1 more | |
| | | Single nucleotide variant (synonymous variant) | Rheumatoid arthritis +1 more | |
| | | Single nucleotide variant (intron variant) | Rheumatoid arthritis +1 more | |
| | | Single nucleotide variant | Rheumatoid arthritis | |
| | | Single nucleotide variant (missense variant) | PADI4-related disorder +2 more | |
| | | Single nucleotide variant (missense variant) | PADI4-related disorder +2 more | |
| | | Single nucleotide variant (missense variant) | PADI4-related disorder +2 more | |
| | | Single nucleotide variant (intron variant) | Rheumatoid arthritis | |
| | | Single nucleotide variant (synonymous variant) | PADI4-related disorder +2 more | |
| | | Single nucleotide variant (missense variant) | UDPglucose-4-epimerase deficiency +1 more | GConflicting classifications of pathogenicity; other |
| | | Single nucleotide variant (missense variant) | UDPglucose-4-epimerase deficiency +2 more | GConflicting classifications of pathogenicity; other |
| | | Single nucleotide variant (nonsense) | Colorectal cancer | |
| | | Single nucleotide variant (missense variant) | Medulloblastoma | |
| | | Single nucleotide variant (missense variant) | Hepatoblastoma | |
| | | Deletion (inframe_deletion) | Endometrial carcinoma | |
| | | Single nucleotide variant (missense variant) | Obesity, association with | |
| | | Single nucleotide variant (missense variant) | Obesity, association with | |
| | | Single nucleotide variant (3 prime UTR variant +1 more) | Pulmonary disease, chronic obstructive, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Pulmonary disease, chronic obstructive, susceptibility to | |
| | CYP4A22, CYP4A22-AS1 (C231R) | Single nucleotide variant (missense variant +1 more) | Pulmonary disease, chronic obstructive, susceptibility to | |
| | AGBL4, AGBL4-AS1 +119 more | Copy number loss | Orofacial cleft 13 | |
| | | Single nucleotide variant (missense variant) | Carnitine palmitoyltransferase II deficiency +5 more | GConflicting classifications of pathogenicity; other |
| | | Single nucleotide variant | Familial hypercholesterolemia | |
| | | Single nucleotide variant (missense variant) | not provided | GLikely benign; association |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Pulmonary disease, chronic obstructive, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Diamond-Blackfan anemia 6 | |
| | ABCA4, LOC126805793 (R1640W +1 more) | Single nucleotide variant (missense variant) | Cone-rod dystrophy 3 +6 more | GPathogenic/Likely pathogenic; other |
| | | Single nucleotide variant (missense variant) | not provided +2 more | |
| | CELSR2, LOC110121285 +1 more | Single nucleotide variant (3 prime UTR variant) | Low density lipoprotein cholesterol level quantitative trait locus 6 | |
| | LOC112577475, RBM15 (Q638K) | Single nucleotide variant (missense variant) | Neuroblastoma | |
| | | Single nucleotide variant (missense variant) | not provided +1 more | GConflicting classifications of pathogenicity; other |
| | | Single nucleotide variant (nonsense +1 more) | not provided +2 more | GConflicting classifications of pathogenicity; other |
| | LIX1L-AS1, LOC126805851 +1 more | Single nucleotide variant (non-coding transcript variant +1 more) | not provided +2 more | GConflicting classifications of pathogenicity; other |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant +1 more) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant +1 more) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant +1 more) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant +1 more) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant +1 more) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant +1 more) | Autism spectrum disorder | |
| | | Single nucleotide variant (intron variant) | Colorectal cancer | |
| | GBA1, LOC106627981 (H294Q +2 more) | Single nucleotide variant (missense variant) | not provided +7 more | GConflicting classifications of pathogenicity; other |
| | | Single nucleotide variant (3 prime UTR variant +1 more) | Calcium oxalate urolithiasis | |
| | | Single nucleotide variant (missense variant) | YOLK SAC TUMOR AND HIGH-GRADE IMMATURE TERATOMA | |
| | | Single nucleotide variant (5 prime UTR variant) | Resistance to Plasmodium vivax infection +2 more | GPathogenic; association; protective |
| | | Deletion (frameshift variant) | not provided | |
| | | Single nucleotide variant (missense variant +1 more) | Systemic lupus erythematosus, susceptibility to +1 more | |
| | | Single nucleotide variant (intron variant) | Pulmonary disease, chronic obstructive, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Pulmonary disease, chronic obstructive, susceptibility to | |
| | | Single nucleotide variant (5 prime UTR variant) | Pulmonary disease, chronic obstructive, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Pulmonary disease, chronic obstructive, susceptibility to | |
| | | Single nucleotide variant (3 prime UTR variant) | Pulmonary disease, chronic obstructive, susceptibility to | |
| | | Single nucleotide variant (3 prime UTR variant) | Pulmonary disease, chronic obstructive, susceptibility to | |
| | | Single nucleotide variant (3 prime UTR variant) | Cholangiocarcinoma | |
| | | Single nucleotide variant (non-coding transcript variant) | Cholangiocarcinoma | |
| | | Single nucleotide variant (missense variant) | CR1-related disorder +1 more | |
| | LOC126806029, LOC129932471 +720 more | Copy number loss | Orofacial cleft 2 | |
| | | Single nucleotide variant (nonsense) | Melioidosis, resistance to +2 more | |
| | | Single nucleotide variant (missense variant) | Glioblastoma | |
| | | Single nucleotide variant (intron variant) | Vascular endothelial growth factor (VEGF) inhibitor response | |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (missense variant) | not specified +4 more | GBenign/Likely benign; other; risk factor |
| | | Single nucleotide variant (missense variant) | Autism spectrum disorder | |
| | | Single nucleotide variant (intron variant) | Lip and oral cavity carcinoma | |
| | | Single nucleotide variant (missense variant) | Irido-corneo-trabecular dysgenesis +4 more | GBenign/Likely benign; other |